Organic Process Research & Development
Page 26 of 29
1
2
3
4
5
6
7
8
9
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
4
5
5
5
5
5
5
5
5
5
5
6
A.; Huang, H.; Huang, L.; Jarosh, M.; Kornecook, T.; Kreiman, C. R.; Ligutti, J.; La, D. S.; Lin,
M.-H. J.; Liu, D.; Moyer, B. D.; Nguyen, H. N.; Peterson, E. A.; Rose, P. E.; Taborn, K.;
Youngblood, B. D.; Yu, V.; Fremeau, R. T. Sulfonamides as Selective Nav1.7 Inhibitors:
Optimizing Potency and Pharmacokinetics While Mitigating Metabolic Liabilities. J. Med.
Chem. 2017, 60, 5969−5989. (c) Graceffa, R. F.; Boezio, A. A.; Able, J.; Altmann, S.; M. Berry,
L.; Boezio, C.; Butler, J. R.; Chu-Moyer, M.; Cooke, M.; DiMauro, E. F.; Dineen, T. A.; Bojic,
E. F.; Foti, R. S.; Fremeau, R. T.; Guzman-Perez, A.; Gao, H.; Gunaydin, H.; Huang, H.; Huang,
L.; Ilch, C.; Jarosh, M.; Kornecook, T.; Kreiman, C. R.; La, D. S.; Ligutti, J.; Milgram, B. C.;
Lin, M.-H. J.; Marx, I. E.; Nguyen, H. N.; Peterson, E. A.; Rescourio, G.; Roberts, J.; Schenkel,
L.; Shimanovich, R.; Sparling, B. A.; Stellwagen, J.; Taborn, K.; Vaida, K. R.; Wang, J.;
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
Yeoman, J.; Yu, V.; Zhu, D.; Moyer, B. D.; Weiss, M. M. Sulfonamides as Selective Na 1.7
v
Inhibitors: Optimizing Potency, Pharmacokinetics, and Metabolic Properties to Obtain
Atropisomeric Quinolinone (AM-0466) that Affords Robust in Vivo Activity. J. Med. Chem.
2
017, 60, 5990−6017. (d) King, G. F.; Vetter, I. No Gain, No Pain: Na 1.7 as an Analgesic
v
Target. ACS Chem. Neurosci. 2014, 5, 749−751. (e) Browne, L.; Lidster, K.; Al-Izki, S.;
Clutterbuck, L.; Posada, C.; Chan, A. W. E.; Riddall, D.; Garthwaite, J.; Baker, D.; Selwood, D.
L. Imidazol-1-ylethylindazole Voltage-Gated Sodium Channel Ligands Are Neuroprotective
during Optic Neuritis in a Mouse Model of Multiple Sclerosis. J. Med. Chem. 2014, 57,
2942−2952. (f) Swain, N. A.; Batchelor, D.; Beaudoin, S.; Bechle, B. M.; Bradley, P. A.; Brown,
A. D.; Brown, B.; Butcher, K. J.; Butt, R. P.; Chapman, M. L.; Denton, S.; Ellis, D.; Galan, S. R.
G.; Gaulier, S. M.; Greener, B. S.; de Groot, M. J.; Glossop, M. S.; Gurrell, I. K.; Hannam, J., M.
S.; Lin, Z.; Markworth, C. J.; Marron, B. E.; Millan, D. S.; Nakagawa, S.; Pike, A.; Printzenhoff,
D.; Rawson, D. J.; Ransley, S. J.; Reister, S. M.; Sasaki, K.; Storer, R. I.; Stupple, P. A.; West,
C. W. Discovery of Clinical Candidate 4‑[2-(5-Amino‑1H‑pyrazol-4-yl)-4-chlorophenoxy]-5-
chloro-2-fluoro ‑ N ‑ 1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and
Optimization of Diaryl Ether Aryl Sulfonamides as Selective Inhibitors of Nav1. J. Med. Chem.
2
017, 60, 7029−7042. (g) Bagal, S. K.; Brown, A. D.; Cox, P. J.; Omoto, K.; Owen, R. M.;
Pryde, D. C.; Sidders, B.; Skerratt, S. E.; Stevens, E. B.; Storer, R. I.; Swain, N. A. Ion Channels
as Therapeutic Targets: A Drug Discovery Perspective. J. Med. Chem. 2013, 56, 593−624. (h)
Blass, B. E. Acyl Sulfonamides Nav1.7 Blockers Useful for the Treatment of Pain. ACS Med.
Chem. Lett. 2018, 9, 161−162. (i) Ali, S. R.; Liu, Z.; Nenov, M. N.; Folorunso, O.; Singh, A.;
Scala, F.; Chen, H.; James, T. F.; Alshammari, M.; Panova-Elektronova, N. I.; White, M. A.;
Zhou, J.; Laezza, F. Functional Modulation of Voltage-Gated Sodium Channels by a FGF14-
Based Peptidomimetic. ACS Chem. Neurosci. 2018, 9, 976−987. (j) de Lera Ruiz, M.; Kraus, R.
L. Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical
Indications. J. Med. Chem. 2015, 58, 7093−7118.
2
(a) Hemeon; I. W.; Safina, B.; Sutherlin, D. Preparation of Fluorinated Aromatic Ethers as
Sodium Channel Blockers Useful in Treatment of Diseases. PCT Int. Appl. (2017),
WO2017035271 A1 20170302. (b) Chowdhury, S.; Dehnhardt, C. M.; Martin, C.; Hasan, A.;
Hemeon, I. W.; Jia, Q.; Jun, L.; Liu, Z.; Ortwine, D. F.; Safina, B.; Sutherlin, D. Preparation of
Substituted Benzamide Compounds. as Sodium Channel Inhibitors. U.S. Pat. Appl. Publ. (2016)
US20160340309 A1 20161124. (c) Ahuja, S.; Mukund, S.; Deng, L.; Khakh, K; Chang, E.; Ho,
H.; Shriver, S.; Young, C.; Lin, S.; Johnson Jr., J. P.; Wu, P.; Li, J.; Coons, M.; Tam, C.;
Brillantes, B.; Sampang, H.; Mortara, K.; Bowman, K. K.; Clark, K. R.; Estevez, A.; Xie, Z.;
Verschoof, H.; Grimwood, M.; Dehnhardt, C.; Andrez; J.-C.; Focken, T.; Sutherlin, D. P.;
ACS Paragon Plus Environment
2
6